Method for screening anti-breast cancer metastasis compounds, and applications of related compounds
An anti-breast cancer and compound technology, applied in biochemical equipment and methods, microbiological measurement/inspection, medical preparations containing active ingredients, etc., can solve problems such as unsuitability, high cost, and difficulty in customizing microarray chips
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0054] Example 1: Discovery of compounds that reverse breast cancer lung metastasis gene profile
[0055] In 2005, the laboratory of Joan Massague in the United States reported that 18 genes were closely related to lung metastasis of breast cancer, of which 15 genes were highly expressed in cells with strong lung metastasis ability of breast cancer, and 3 genes were low expressed, as shown in Table 1. It suggests that if the expression of these 18 genes is reversed in cells with strong lung metastasis ability of breast cancer, it is possible to inhibit the occurrence of lung metastasis of breast cancer.
[0056] Table 1: Names, functional classification and expression of genes related to lung metastasis of breast cancer
[0057]
[0058]
[0059] Through large-scale compound screening, we expect to find active compounds that can reverse the expression direction of the above genes in breast cancer lung metastasis cells. Specific steps are as follows:
[0060] 1. Design ...
Embodiment 2
[0106] Example 2: Compound F (GSK1070916, N'-[4-[4-[2-[3-[(dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-B]pyridine -4-yl]-1-ethyl-1H-pyrazol-3-yl]phenyl]-N,N-dimethylurea), compound G (Ponatinib, Ponatinib) inhibit MDA-MB-231 cell migration assay
[0107] MDA-MB-231 is a breast cancer cell line commonly used in experiments. It has fast growth, strong cell migration ability, and also has high metastasis ability in animal experiments. Cell migration is an essential step in cancer metastasis. Inhibiting cancer cell migration can effectively inhibit cancer cell metastasis.
[0108] Add 800 μL of 1640 medium containing 10% FBS and 1 μM compound into wells of a 24-well culture plate. Place the Transwell chambers on a 24-well plate. MDA-MB-231 cells cultured to the logarithmic phase were taken, digested with trypsin, and centrifuged to collect the cell pellet. Adjust the cell concentration to 2.5 × 10 with serum-free 1640 medium containing 1 μM compound 5 cells / mL, slowly and eve...
Embodiment 3
[0113] Example 3: Compound A affects the cell cloning ability of MDA-MB-231
[0114] The cloning ability of cells is an important guarantee for the survival and growth of cancer cells after metastasis to distant sites, and is an important indicator for evaluating cancer metastasis.
[0115]The MDA-MB-231 cells cultured to the logarithmic phase were taken, digested with trypsin, and the cell pellet was collected. The cells were suspended in 1640 medium containing 10% FBS and 1% double antibody, and seeded in a 6-well plate with 500 cells per well. After 12 hours, add DMSO to the culture medium of one group, add compound A to the final concentration of 1 μM, 0.33 μM, and 0.11 μM respectively in one group, culture in a CO2 incubator at 37°C, and change the medium containing DMSO or compound A every 3 days . On the 10th day, discard the medium, and stain with 0.1% crystal violet for 30 min. Wash with PBS after staining, take pictures with imager, and each experiment has 3 biolo...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com